Company News
Brooks Laboratories Incorporates Wholly Owned Subsidiary
Brooks Laboratories incorporated a wholly owned subsidiary named Abridge Speciality Limited on July 2, 2026.
The subsidiary has an authorized share capital of ₹1,00,000 and will operate in pharmaceuti